Poultry

Advancements in precision farming and modern analytics are significantly impacting the poultry sector.

Novel technologies improving biosecurity

THE ACTIONS AND measures taken to prevent diseases being introduced through animals are crucial to ensure the safety of food.

Some recent technological advancements are leading change in poultry production.

Bacteriophage technology

Poultry farmers in selected markets already benefit from using Proteon Pharmaceutics’ bacteriophage technology to ensure biosecurity through the waterline and to improve the efficiency of the production.

The antimicrobial resistance threat has spurred recent investments in bacteriophageal technologies. Modern analytics and omics technologies have enabled the bacteriophage candidates to be screened and identified for a specific bacterial challenge, with significant implications for feed and food safety. This new technology is already being used in the animal feed industry.

Jarosław Dastych, CEO, Proteon Pharmaceuticals, commented, “We strongly

Advanced technologies are helping farmers improve biosecurity.

believe that our technology might be considered as the future of animal health and nutrition and will help to reduce antibiotic use and antimicrobial resistance.”

Proteon’s bacteriophage technology helps ensure biosecurity through the waterline and improves the efficiency of production.

Incineration solution

Agricultural incinerator manufacturer Addfield Environmental Systems has introduced a highly flexible solution for large broiler houses and poultry farms with the release and installation of the first A50L in the UK.

This new solution for poultry farmers helps to maintain biosecurity and manage their fallen livestock efficiently.

The manufacturer said that the A50L had taken agricultural incineration to new levels by being able to achieve almost continuous loading and operation.

James Grant, business development director at Addfield, said, “It has been a very pleasant result taking off as it has in the UK. We work with farms of all sizes from micro small holdings through to some of the largest pig and poultry producers in the world."

Smart solutions

Several innovations are constantly working together with smart solutions to achieve precision farming.

GPS tracking collars, smart sensors and tags can assist livestock farmers in monitoring and ensuring biosecurity through a smart system of access control.

Biosecurity is of great importance to prevent new outbreaks of contagious diseases, which again, may lead to enormous losses. Together with this, the use of new and innovative feed ingredients, enhancing the immune system of animals is important. h

Boehringer Ingelheim unveils vaccine for three diseases

BOEHRINGER INGELHEIM ANIMAL Health has launched a first-of-its-kind vaccine to protect poultry from Infectious Laryngotracheitis, Marek’s Disease and Infectious Bursal Disease (classic and variant types).

“This new trivalent vaccine provides a strong immune foundation, optimises protection for flocks and offers reliable protection,” said Matt Nelson, head of Boehringer Ingelheim Animal Health’s US poultry business.

The three-in-one vaccine is the latest addition in the VAXXITEK family of vaccines for poultry. It uses the same bioengineering platform as VAXXITEK HVT+IBD, which has protected more than 100 billion birds from Marek’s Disease and Infectious Bursal Disease in more than 75 countries since its introduction in 2006.

Infectious Laryngotracheitis (ILT) is an acute viral respiratory disease caused by Gallid herpesvirus type 1 in poultry. There is no effective treatment for ILT, and the virus persists for life in affected birds. The disease can cause significant economic losses.

Boehringer Ingelheim Animal Health’s existing non-vectored vaccine protects against ILT. The new trivalent vaccine is a

The three-in-one vaccine is the latest addition in the VAXXITEK family of vaccines for poultry.

vectored vaccine that protects ILT along with two other health threats to poultry: Marek’s Disease and Infectious Bursal Disease.

The company will manufacture its new vaccine in Gainesville, Georgia, where it produces 60 billion doses of poultry vaccine per year for use in the US and around 60 other countries.